BioSpace News Archive

Policy

Barr Pharmaceuticals, Inc. To Pay 22.5 Million USD To Settle Warfarin Law Suit With Novartis Corporation Units

June 12, 2006
·
4 min read
Business

ESTECH Signs Distribution Agreement With Neoprobe Corporation

June 12, 2006
·
1 min read
Drug Development

Newly Released Phase III Studies For JANUVIA(TM), Merck & Co., Inc.'s Investigational Once-Daily Medicine For Type 2 Diabetes, Showed Significantly Reduced Blood Sugar Levels When Used As Monotherapy Or As Add-On Treatment

June 12, 2006
·
1 min read
Drug Development

Eli Lilly and Company, Alkermes. Amylin Pharmaceuticals, Inc. Release: Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control ln Patients With Type 2 Diabetes

June 12, 2006
·
1 min read
Drug Development

Merck & Co., Inc. And Schering-Plough Corporation Release: New Study Showed VYTORIN(R) Superior To Lipitor In Reducing LDL ‘Cholesterol In Patients With Type II Diabetes At The Recommended Usual Starting Doses

June 12, 2006
·
9 min read
Drug Development

Metabolex, Inc. Initiates Phase 2/3 Trial Of Metaglidasen In Patients With Type 2 Diabetes

June 12, 2006
·
1 min read
Drug Development

MediciNova, Inc. Announces Results From A Phase II/III Generalized Anxiety Disorder Trial With MN-305

June 12, 2006
·
1 min read
Business

Immunicon Corporation Assay Utilized By Pfizer Inc. In Phase I Drug Study

June 12, 2006
·
1 min read
Business

Theravance, Inc. Announces Second Compound’s Entry Into Phase 2b Clinical Program In Beyond Advair Collaboration With GlaxoSmithKline

June 12, 2006
·
1 min read
Drug Development

Panacos Pharmaceuticals Inc. Announces Initiation Of Phase 2b Clinical Trial Of First-In-Class HIV Maturation Inhibitor, Bevirimat (PA-457)

June 12, 2006
·
1 min read